2023

Goulding, A. et al. (2023) Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study. Archives of Disease in Childhood, (doi: 10.1136/archdischild-2022-324713) (PMID:36609412) (Early Online Publication)

2022

Stock, S. J. et al. (2022) Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet Respiratory Medicine, 10(12), pp. 1129-1136. (doi: 10.1016/S2213-2600(22)00360-5) (PMID:36216011) (PMCID:PMC9708088)

Gómez-Castañeda, E., Hopcroft, L. E.M. , Rogers, S. , Munje, C., Bittencourt-Silvestre, J., Copland, M. , Vetrie, D. , Holyoake, T. and Jørgensen, H. G. (2022) Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy. Cancers, (doi: 10.3390/cancers14215253)

Calvert, C. et al. (2022) A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection. Nature Communications, 13, 6124. (doi: 10.1038/s41467-022-33937-y) (PMID:36253471) (PMCID:PMC9574832)

Stewart, G. D. et al. (2022) A phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). British Journal of Cancer, 127(6), pp. 1051-1060. (doi: 10.1038/s41416-022-01883-7) (PMID:35739300) (PMCID:PMC9470559)

Stock, S. J. et al. (2022) Cohort profile: the Covid-19 in pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy. International Journal of Epidemiology, 51(5), e245-e255. (doi: 10.1093/ije/dyab243) (PMID:34977922) (PMCID:PMC9557859)

Stock, S. J. et al. (2022) SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28(3), pp. 504-512. (doi: 10.1038/s41591-021-01666-2) (PMID:35027756)

2018

Salomé, M. , Hopcroft, L. and Keeshan, K. (2018) Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis. Experimental Hematology, 66, 63-78.e13. (doi: 10.1016/j.exphem.2018.07.005) (PMID:30031847)

Mitchell, R. et al. (2018) Targeting BCR-ABL independent TKI resistance in chronic myeloid leukaemia by mTOR and autophagy inhibition. Journal of the National Cancer Institute, 110(5), pp. 467-478. (doi: 10.1093/jnci/djx236) (PMID:29165716) (PMCID:PMC5946859)

Pellicano, F. et al. (2018) Hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood, 131(14), pp. 1532-1544. (doi: 10.1182/blood-2017-05-783845) (PMID:29437554) (PMCID:PMC6027092)

Zhang, B. et al. (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nature Medicine, 24, pp. 450-462. (doi: 10.1038/nm.4499) (PMID:29505034) (PMCID:PMC5965294)

2017

Tarafdar, A. et al. (2017) CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. Blood, 129(2), pp. 199-208. (doi: 10.1182/blood-2016-09-742049) (PMID:27793879) (PMCID:PMC5305055)

Hopcroft, L. E. , Abraham, S. A. and Holyoake, T. L. (2017) Validating a network hub in leukaemia stem cells. Oncoscience, 4(1-2), pp. 3-4. (doi: 10.18632/oncoscience.339) (PMID:28484726) (PMCID:PMC5361640)

Jackson, L. , Gómez-Castañeda, E., Jørgensen, H. G. , Hopcroft, L. E.M. , Rogers, S. , Holyoake, T. L. and Huang, X. (2017) Oncogene addiction in chronic myeloid leukaemia. In: eLS. John Wiley & Sons, Ltd, pp. 1-9. ISBN 9780470015902 (doi: 10.1002/9780470015902.a0024464)

2016

Scott, M. T. et al. (2016) Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition. Cancer Discovery, 6(11), pp. 1248-1257. (doi: 10.1158/2159-8290.CD-16-0263) (PMID:27630125) (PMCID:PMC6538532)

Sinclair, A. et al. (2016) CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood, 128(3), pp. 371-383. (doi: 10.1182/blood-2015-08-661785) (PMID:27222476) (PMCID:PMC4991087)

Abraham, S. A. et al. (2016) Dual targeting of P53 and C-MYC induces selective elimination of leukemic stem cells. Nature, 534(7607), pp. 341-346. (doi: 10.1038/nature18288) (PMID:27281222) (PMCID:PMC4913876)

Gómez-Castañeda, E., Hopcroft, L.E.M. , Rogers, S. , Jorgensen, H.G. , Pellicano, F., Vetrie, D. , Copland, M. , Grimmond, S. and Holyoake, T.L. (2016) Uncovering the BCR-ABL1 Tyrosine Kinase Independent Signature in Chronic Myeloid Leukaemia Stem Cells. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. (doi: 10.1111/bjh.14019)

Jackson, L., Hopcroft, L.E.M. , Rogers, S. , Jorgensen, H., Pellicano, F., Wells, C., Mosbergen, R., Chen, T., Vetrie, D. and Holyoake, T.L. (2016) Identifying Genes and Pathways Deregulated in Chronic Myeloid Leukaemia Stem Cells Through Meta-Analysis of Transcriptomic Data. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. (doi: 10.1111/bjh.14019)

Michie, A.M. , Tarafdar, A., Gallipoli, P., Pellicano, F., Hopcroft, L. , Korfi, K., Cassels, J., Jorgensen, H.J. , Vetrie, D. and Holyoake, T.L. (2016) CML Cells Actively Evade Host Immune Surveillance Through Cytokine-Mediated Downregulation of MHC-I I Expression. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. p. 117. (doi: 10.1111/bjh.14019)

Zhang, B., Chu, S., Agarwal, P., Campbell, V. L., Hopcroft, L. , Jørgensen, H. G. , Lin, A., Gaal, K., Holyoake, T. L. and Bhatia, R. (2016) Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor treated CML stem cells. Blood, 128(23), pp. 2671-2682. (doi: 10.1182/blood-2015-11-679928) (PMID:27621307) (PMCID:PMC5146743)

2015

Hopcroft, L. E. M. , Calderhead, B., Gallipoli, P., Holyoake, T. L. and Girolami, M. A. (2015) Bayesian inference for model selection: an application to aberrant signalling pathways in chronic myeloid leukaemia. In: Markowetz, F. and Boutros, M. (eds.) Systems Genetics: Linking Phenotypes to Genotypes. Series: Cambridge series in systems genetics. Cambridge University Press, pp. 161-190. ISBN 9781107013841

2014

Gallipoli, P., Cook, A., Rhodes, S. , Hopcroft, L. , Wheadon, H. , Whetton, A. D., Jorgensen, H. G. , Bhatia, R. and Holyoake, T. L. (2014) JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD34+ cells in vitro and in vivo. Blood, 124(9), pp. 1492-1501. (doi: 10.1182/blood-2013-12-545640) (PMID:24957147) (PMCID:PMC4148771)

Abraham, S., Hopcroft, L. , Bhatia, R., Koschmieder, S., Whetton, A. and Holyoake, T. (2014) Models to study chronic myeloid leukemia cancer stem cells. In: Rajasekhar, V. (ed.) Cancer Stem Cells. Wiley-Blackwell. ISBN 9781118356166 (doi: 10.1002/9781118356203.ch9)

Pellicano, F. et al. (2014) The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells, 32(9), pp. 2324-2337. (doi: 10.1002/stem.1748) (PMID:24806995) (PMCID:PMC4282530)

Toofan, P., Irvine, D., Hopcroft, L. , Copland, M. and Wheadon, H. (2014) The role of the bone morphogenetic proteins in leukaemic stem cell persistence. Biochemical Society Transactions, 42(4), pp. 809-815. (doi: 10.1042/BST20140037)

2013

Abraham, S., Hopcroft, L. , Carrick, E., Williamson, A., Pierce, A., Cassels, J., Pellicano, F., Whetton, A. and Holyoake, T. L. (2013) p53 and c-Myc are critical signaling hubs that maintain chronic myeloid leukemia. In: 55th American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, USA, 7-10 Dec 2013, p. 1465.

Rhodes, S. , Copland, M. , Hopcroft, L. , Sayeski, P. and Wheadon, H. (2013) Identification of JAK2 dependent transcriptional regulators in CML. In: 42nd Annual Scientific Meeting of the ISEH – Society for Hematology and Stem Cells, Vienna, Austria, 22-25 Aug 2013, S47-S47.

2011

Izarzugaza, J. M. G., Hopcroft, L. E. M. , Baresic, A., Orengo, C. A., Martin, A. C. R. and Valencia, A. (2011) Characterization of pathogenic germline mutations in human protein kinases. BMC Bioinformatics, 12(Sup. 4), S1. (doi: 10.1186/1471-2105-12-S4-S1)

2010

Hopcroft, L. E.M. , McBride, M. W. , Harris, K. J., Sampson, A. K., McClure, J. D. , Graham, D. , Young, G., Holyoake, T. L., Girolami, M. A. and Dominiczak, A. F. (2010) Predictive response-relevant clustering of expression data provides insights into disease processes. Nucleic Acids Research, 38(20), pp. 6831-6840. (doi: 10.1093/nar/gkq550)

Baresić, A., Hopcroft, L. E. M. , Rogers, H. H., Hurst, J. M. and Martin, A. C.R. (2010) Compensated pathogenic deviations: analysis of structural effects. Journal of Molecular Biology, 396(1), pp. 19-30. (doi: 10.1016/j.jmb.2009.11.002)

McBride, M. , Hopcroft, L. , Harris, K., McClure, J. , Graham, D. , Girolami, M. and Dominiczak, M. (2010) Insights into Salt-Sensitive Hypertension Using Response-Relevant Clustering. In: 20th Annual Meeting of the European Society of Hypertension, Oslo, Norway, 18-21 June, E342-E342.

2009

Izarzugaza, J. M.G., Baresic, A., McMillan, L. E.M. , Yeats, C., Clegg, A. B., Orengo, C. A., Martin, A. C.R. and Valencia, A. (2009) An integrated approach to the interpretation of single amino acid polymorphisms within the framework of CATH and Gene3D. BMC Bioinformatics, 10(Sup. 8), S5. (doi: 10.1186/1471-2105-10-S8-S5)

Hurst, J. M., McMillan, L. E. M. , Porter, C. T., Allen, J., Fakorede, A. and Martin, A. C. R. (2009) The SAAPdb web resource: a large-scale structural analysis of mutant proteins. Human Mutation, 30(4), pp. 616-624. (doi: 10.1002/humu.20898)

Harris, K., McMillan, L. and Girolami, M. (2009) Inferring meta-covariates in classification. In: 4th IAPR International Conference on Pattern Recognition in Bioinformatics, Sheffield, UK, 7-9 Sept 2009, pp. 150-161. (doi: 10.1007/978-3-642-04031-3_14)

2008

McMillan, L. E.M. and Martin, A. C.R. (2008) Automatically extracting functionally equivalent proteins from SwissProt. BMC Bioinformatics, 9, p. 418. (doi: 10.1186/1471-2105-9-418)

Articles

Goulding, A. et al. (2023) Confirmed SARS-CoV-2 infection in Scottish neonates 2020–2022: a national, population-based cohort study. Archives of Disease in Childhood, (doi: 10.1136/archdischild-2022-324713) (PMID:36609412) (Early Online Publication)

Stock, S. J. et al. (2022) Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study. Lancet Respiratory Medicine, 10(12), pp. 1129-1136. (doi: 10.1016/S2213-2600(22)00360-5) (PMID:36216011) (PMCID:PMC9708088)

Gómez-Castañeda, E., Hopcroft, L. E.M. , Rogers, S. , Munje, C., Bittencourt-Silvestre, J., Copland, M. , Vetrie, D. , Holyoake, T. and Jørgensen, H. G. (2022) Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy. Cancers, (doi: 10.3390/cancers14215253)

Calvert, C. et al. (2022) A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection. Nature Communications, 13, 6124. (doi: 10.1038/s41467-022-33937-y) (PMID:36253471) (PMCID:PMC9574832)

Stewart, G. D. et al. (2022) A phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). British Journal of Cancer, 127(6), pp. 1051-1060. (doi: 10.1038/s41416-022-01883-7) (PMID:35739300) (PMCID:PMC9470559)

Stock, S. J. et al. (2022) Cohort profile: the Covid-19 in pregnancy in Scotland (COPS) dynamic cohort of pregnant women to assess effects of viral and vaccine exposures on pregnancy. International Journal of Epidemiology, 51(5), e245-e255. (doi: 10.1093/ije/dyab243) (PMID:34977922) (PMCID:PMC9557859)

Stock, S. J. et al. (2022) SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature Medicine, 28(3), pp. 504-512. (doi: 10.1038/s41591-021-01666-2) (PMID:35027756)

Salomé, M. , Hopcroft, L. and Keeshan, K. (2018) Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis. Experimental Hematology, 66, 63-78.e13. (doi: 10.1016/j.exphem.2018.07.005) (PMID:30031847)

Mitchell, R. et al. (2018) Targeting BCR-ABL independent TKI resistance in chronic myeloid leukaemia by mTOR and autophagy inhibition. Journal of the National Cancer Institute, 110(5), pp. 467-478. (doi: 10.1093/jnci/djx236) (PMID:29165716) (PMCID:PMC5946859)

Pellicano, F. et al. (2018) Hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood, 131(14), pp. 1532-1544. (doi: 10.1182/blood-2017-05-783845) (PMID:29437554) (PMCID:PMC6027092)

Zhang, B. et al. (2018) Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nature Medicine, 24, pp. 450-462. (doi: 10.1038/nm.4499) (PMID:29505034) (PMCID:PMC5965294)

Tarafdar, A. et al. (2017) CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression. Blood, 129(2), pp. 199-208. (doi: 10.1182/blood-2016-09-742049) (PMID:27793879) (PMCID:PMC5305055)

Hopcroft, L. E. , Abraham, S. A. and Holyoake, T. L. (2017) Validating a network hub in leukaemia stem cells. Oncoscience, 4(1-2), pp. 3-4. (doi: 10.18632/oncoscience.339) (PMID:28484726) (PMCID:PMC5361640)

Scott, M. T. et al. (2016) Epigenetic reprogramming sensitizes CML stem cells to combined EZH2 and tyrosine kinase inhibition. Cancer Discovery, 6(11), pp. 1248-1257. (doi: 10.1158/2159-8290.CD-16-0263) (PMID:27630125) (PMCID:PMC6538532)

Sinclair, A. et al. (2016) CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood, 128(3), pp. 371-383. (doi: 10.1182/blood-2015-08-661785) (PMID:27222476) (PMCID:PMC4991087)

Abraham, S. A. et al. (2016) Dual targeting of P53 and C-MYC induces selective elimination of leukemic stem cells. Nature, 534(7607), pp. 341-346. (doi: 10.1038/nature18288) (PMID:27281222) (PMCID:PMC4913876)

Zhang, B., Chu, S., Agarwal, P., Campbell, V. L., Hopcroft, L. , Jørgensen, H. G. , Lin, A., Gaal, K., Holyoake, T. L. and Bhatia, R. (2016) Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor treated CML stem cells. Blood, 128(23), pp. 2671-2682. (doi: 10.1182/blood-2015-11-679928) (PMID:27621307) (PMCID:PMC5146743)

Gallipoli, P., Cook, A., Rhodes, S. , Hopcroft, L. , Wheadon, H. , Whetton, A. D., Jorgensen, H. G. , Bhatia, R. and Holyoake, T. L. (2014) JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of chronic phase CML CD34+ cells in vitro and in vivo. Blood, 124(9), pp. 1492-1501. (doi: 10.1182/blood-2013-12-545640) (PMID:24957147) (PMCID:PMC4148771)

Pellicano, F. et al. (2014) The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells, 32(9), pp. 2324-2337. (doi: 10.1002/stem.1748) (PMID:24806995) (PMCID:PMC4282530)

Toofan, P., Irvine, D., Hopcroft, L. , Copland, M. and Wheadon, H. (2014) The role of the bone morphogenetic proteins in leukaemic stem cell persistence. Biochemical Society Transactions, 42(4), pp. 809-815. (doi: 10.1042/BST20140037)

Izarzugaza, J. M. G., Hopcroft, L. E. M. , Baresic, A., Orengo, C. A., Martin, A. C. R. and Valencia, A. (2011) Characterization of pathogenic germline mutations in human protein kinases. BMC Bioinformatics, 12(Sup. 4), S1. (doi: 10.1186/1471-2105-12-S4-S1)

Hopcroft, L. E.M. , McBride, M. W. , Harris, K. J., Sampson, A. K., McClure, J. D. , Graham, D. , Young, G., Holyoake, T. L., Girolami, M. A. and Dominiczak, A. F. (2010) Predictive response-relevant clustering of expression data provides insights into disease processes. Nucleic Acids Research, 38(20), pp. 6831-6840. (doi: 10.1093/nar/gkq550)

Baresić, A., Hopcroft, L. E. M. , Rogers, H. H., Hurst, J. M. and Martin, A. C.R. (2010) Compensated pathogenic deviations: analysis of structural effects. Journal of Molecular Biology, 396(1), pp. 19-30. (doi: 10.1016/j.jmb.2009.11.002)

Izarzugaza, J. M.G., Baresic, A., McMillan, L. E.M. , Yeats, C., Clegg, A. B., Orengo, C. A., Martin, A. C.R. and Valencia, A. (2009) An integrated approach to the interpretation of single amino acid polymorphisms within the framework of CATH and Gene3D. BMC Bioinformatics, 10(Sup. 8), S5. (doi: 10.1186/1471-2105-10-S8-S5)

Hurst, J. M., McMillan, L. E. M. , Porter, C. T., Allen, J., Fakorede, A. and Martin, A. C. R. (2009) The SAAPdb web resource: a large-scale structural analysis of mutant proteins. Human Mutation, 30(4), pp. 616-624. (doi: 10.1002/humu.20898)

McMillan, L. E.M. and Martin, A. C.R. (2008) Automatically extracting functionally equivalent proteins from SwissProt. BMC Bioinformatics, 9, p. 418. (doi: 10.1186/1471-2105-9-418)

Book Sections

Jackson, L. , Gómez-Castañeda, E., Jørgensen, H. G. , Hopcroft, L. E.M. , Rogers, S. , Holyoake, T. L. and Huang, X. (2017) Oncogene addiction in chronic myeloid leukaemia. In: eLS. John Wiley & Sons, Ltd, pp. 1-9. ISBN 9780470015902 (doi: 10.1002/9780470015902.a0024464)

Hopcroft, L. E. M. , Calderhead, B., Gallipoli, P., Holyoake, T. L. and Girolami, M. A. (2015) Bayesian inference for model selection: an application to aberrant signalling pathways in chronic myeloid leukaemia. In: Markowetz, F. and Boutros, M. (eds.) Systems Genetics: Linking Phenotypes to Genotypes. Series: Cambridge series in systems genetics. Cambridge University Press, pp. 161-190. ISBN 9781107013841

Abraham, S., Hopcroft, L. , Bhatia, R., Koschmieder, S., Whetton, A. and Holyoake, T. (2014) Models to study chronic myeloid leukemia cancer stem cells. In: Rajasekhar, V. (ed.) Cancer Stem Cells. Wiley-Blackwell. ISBN 9781118356166 (doi: 10.1002/9781118356203.ch9)

Conference or Workshop Item

Gómez-Castañeda, E., Hopcroft, L.E.M. , Rogers, S. , Jorgensen, H.G. , Pellicano, F., Vetrie, D. , Copland, M. , Grimmond, S. and Holyoake, T.L. (2016) Uncovering the BCR-ABL1 Tyrosine Kinase Independent Signature in Chronic Myeloid Leukaemia Stem Cells. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. (doi: 10.1111/bjh.14019)

Jackson, L., Hopcroft, L.E.M. , Rogers, S. , Jorgensen, H., Pellicano, F., Wells, C., Mosbergen, R., Chen, T., Vetrie, D. and Holyoake, T.L. (2016) Identifying Genes and Pathways Deregulated in Chronic Myeloid Leukaemia Stem Cells Through Meta-Analysis of Transcriptomic Data. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. (doi: 10.1111/bjh.14019)

Michie, A.M. , Tarafdar, A., Gallipoli, P., Pellicano, F., Hopcroft, L. , Korfi, K., Cassels, J., Jorgensen, H.J. , Vetrie, D. and Holyoake, T.L. (2016) CML Cells Actively Evade Host Immune Surveillance Through Cytokine-Mediated Downregulation of MHC-I I Expression. 36th World Congress of the International Society of Hematology, Glasgow, Scotland, 18-21 Apr 2016. p. 117. (doi: 10.1111/bjh.14019)

Conference Proceedings

Abraham, S., Hopcroft, L. , Carrick, E., Williamson, A., Pierce, A., Cassels, J., Pellicano, F., Whetton, A. and Holyoake, T. L. (2013) p53 and c-Myc are critical signaling hubs that maintain chronic myeloid leukemia. In: 55th American Society of Hematology Annual Meeting and Exposition, New Orleans, LA, USA, 7-10 Dec 2013, p. 1465.

Rhodes, S. , Copland, M. , Hopcroft, L. , Sayeski, P. and Wheadon, H. (2013) Identification of JAK2 dependent transcriptional regulators in CML. In: 42nd Annual Scientific Meeting of the ISEH – Society for Hematology and Stem Cells, Vienna, Austria, 22-25 Aug 2013, S47-S47.

McBride, M. , Hopcroft, L. , Harris, K., McClure, J. , Graham, D. , Girolami, M. and Dominiczak, M. (2010) Insights into Salt-Sensitive Hypertension Using Response-Relevant Clustering. In: 20th Annual Meeting of the European Society of Hypertension, Oslo, Norway, 18-21 June, E342-E342.

Harris, K., McMillan, L. and Girolami, M. (2009) Inferring meta-covariates in classification. In: 4th IAPR International Conference on Pattern Recognition in Bioinformatics, Sheffield, UK, 7-9 Sept 2009, pp. 150-161. (doi: 10.1007/978-3-642-04031-3_14)